Guest: Lars Bode, PhD

Guest: Sharon Groh-Wargo PhD, RD, LD

Guest: Terry S. Johnson, RNC, APN, NNP-BC, CLEC, MN

Drs. Lars Bode and Sharon Groh-Wargo and Neonatal Nurse Practitioner Terry Johnson discuss Human Milk Oligosaccharides (HMOs) and their impact on developing infant immunity and supplementation of human milk. Topics to be covered include the key components of human milk that enhance infant immunity, the impact of prebiotic Human Milk Oligosaccharides (HMOs) on developing infant immunity and digestive function, safety and efficacy of prebiotic HMOs, obesity and weight loss with breast-fed versus formula-fed infants, and limitations of using infant formula containing palm olein and other plant derived palmitic acid sources.

Guest: Lars Bode, PhD

Guest: Sharon Groh-Wargo PhD, RD, LD

Guest: Terry S. Johnson, RNC, APN, NNP-BC, CLEC, MN

Drs. Lars Bode and Sharon Groh-Wargo and Neonatal Nurse Practitioner Terry Johnson discuss Human Milk Oligosaccharides (HMOs) and their impact on developing infant immunity and supplementation of human milk. Topics to be covered include the key components of human milk that enhance infant immunity, the impact of prebiotic Human Milk Oligosaccharides (HMOs) on developing infant immunity and digestive function, safety and efficacy of prebiotic HMOs, obesity and weight loss with breast-fed versus formula-fed infants, and limitations of using infant formula containing palm olein and other plant derived palmitic acid sources.

This audio enduring activity consists of two concise and engaging TED-style presentations and question and answer (Q&A) sessions. Two expert rheumatology faculty will use medical storytelling to take participants on a virtual tour through relevant data and recommendations on the management of RA and comorbidities in the United States and globally. The faculty will then comment on each other’s presentations and respond to questions from peer rheumatologists.

Guest: Warner K. Huh, MD

Guest: Thomas C. Wright, Jr., MD

HPV experts, Drs. Warner Huh and Tom Wright discuss the potential of extended HPV genotype testing in high-risk HPV screening for cervical cancer, and the impact that this may have on the current cervical cancer algorithms.

Guest: Khurshid A. Guru, MD

In this segment, Dr. Khurshid Guru shares what healthcare providers need to know when discussing how to select an appropriate cancer surgeon and institution with their patients. He will also explore the role metrics play in evaluating how surgeries are performed throughout the U.S. This activity is the last in a series of eight in-depth discussions with oncology thought leaders at the Roswell Park Cancer Institute in Buffalo, New York, targeting Primary Care and Family physicians. This series was made possible through the generous support of BlueCross BlueShield of Western New York. Dr. Khurshid Guru shares what healthcare providers need to know when discussing how to select an appropriate cancer surgeon and institution with their patients. He will also explore the role metrics play in evaluating how surgeries are performed throughout the U.S.

Host: Jennifer Caudle, DO

Guest: Warner K. Huh, MD

HPV expert, Dr. Warner Huh shares why it is important to test for HPV genotypes beyond HPV 16 and HPV 18.

Host: Jennifer Caudle, DO

Guest: Warner K. Huh, MD

Dr. Warner Huh shares the clinical importance of primary high-risk HPV testing, challenges in integrating co-testing and primary HPV testing in clinical practice, as well as why choose one over the other for individual patients.

Join us as Lawrence Sherman speaks with Dr. Andrew Chan on the utility of NEDA-3 and NEDA-4 in MS treatment, as well as other considerations to improve MS treatment monitoring and the potential role of cladribine in the management of MS.

This interview was conducted while at the Multiple sclerosis: meeting unmet needs through scientific discoveries and clinical practice conference. This international conference was conducted by one of our partners, EXCEMED.

STATEMENT:

As of August 2018, Cladribine was approved in Europe for the treatment of highly active relapsing multiple sclerosis (RMS). All studies presented in this education are still accurate. To learn more about this approval, click here.

Join us as Lawrence Sherman speaks with Dr. Amit Bar-Or on the prevalence of MS globally, the interplay of T cells and B cells in the pathogenesis of MS and the role of GM-CSF producing B cells in MS.

This interview was conducted while at the Multiple sclerosis: meeting unmet needs through scientific discoveries and clinical practice conference. This international conference was conducted by one of our partners, EXCEMED.

Host: Jennifer Caudle, DO

Guest: Nancy Reau, MD, FAASLD, AGAF

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular carcinoma, and death from liver disease in the United States. Given the significant morbidity and mortality associated with the disease, HCV testing is recommended for all individuals born between 1945 and 1965 and those with specific risk behaviors, exposures, and comorbid conditions. However, studies suggest that risk assessment and HCV testing are suboptimal, with care coordination between primary and specialty care needing improvement. In this CME activity, Dr. Nancy Reau will discuss the risk factors associated with HCV, recommendations for screening, and best practices for implementing HCV testing as well as linkage to care. She will also provide practical tips for improving HCV co-management between primary care clinicians and specialists. Click here to view additional topics related to this special series on infectious diseases.